Page 8 - HFA Annual Report 2015
P. 8

Year in Review | Outreach/Advocacy


         Changing or Protecting Policies that Impact the Lives of
         People Living with Bleeding Disorders.





              dvocacy is at the heart of all we do at HFA. Our unwavering commu-
          Anity-centered commitment has contributed to building trust and true
          community engagement. Our practical, hands-on advocacy materials help
          community members navigate the healthcare system and our support
          efforts empower members to advocate, individually and collectively. Our key
          issues include access and  affordability  to  care  and  treatment,  safety  of
          therapies  and  integrity of data collection.  Some  examples  of  specific     Advocacy educational
          advocacy outcomes and accomplishments in 2015 include:                   19 programs delivered at
                                                                                   local meetings
          •  Assisted dozens of community members with individual support concerning
           payer issues, including, but not limited to, providing written support and tes-
           timony in appeals processes, and providing support and advice in obtaining     Letters submitted
           individual exceptions to prohibitive decisions, denials or policies.    18 to executive agencies
                                                                                   on issues like discriminatory
          •  Solicited and published personal accounts of advocacy stories of community   tiering practices, biosimilars,
           families in our quarterly newsletter, Dateline Federation.
                                                                                   and the 340B drug discount
          •  Created toolkits for community members to use when advocating for issues in   pricing program
           their state that includes issue briefs, policy updates, sample letters and talking
           points in areas such as specialty tiers, biosimilars, etc.                     Dear Addys (Q&A on
          •  Supported our 43 member organizations with testimony, written letters, and   16 healthcare & insurance
           coalition-building as they sought to pass legislation about the use of specialty   issues) posted to HFA’s website
           tiers, prior authorization, Medicaid managed care, and other coverage issues.
                                                                                             Meetings of Advocacy
                                                                                   10 Working Group
            “  I advocate for the bleeding disorders community
            to provide help for our families, education for people                        State-based
            who do not know about bleeding disorders, and a                        4 legislative days
            better life for my son as we deal with his severe
                                 ”                                                 4  advocacy summits
            hemophilia type A.                                                            State-based coalition
   3   4   5   6   7   8   9   10   11   12   13